Technical Analysis for PTEO - Proteo, Inc

Grade Last Price % Change Price Change
grade F 0.03 0.00% 0.0000
PTEO closed unchanged on Thursday, July 25, 2019, on 30 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical PTEO trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%

Older signals for PTEO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Proteo, Inc. is a clinical-stage drug development company. The Company intends to develop, promote and market pharmaceuticals and other biotech products. The Company's focus is on the development of anti-inflammatory treatments for rare diseases with unmet needs. The Company is engaged in the development of pharmaceuticals based on the body's own tools and weapons to fight inflammatory diseases. The Company is focusing its research on the development of drugs based on the human protein, Elafin. The Company has obtained Orphan drug designations within the European Union for the use of Elafin for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension, as well as for the treatment of esophageal cancer. Within the United States, it has obtained Orphan drug designations for the use of Elafin for the treatment of pulmonary arterial hypertension, as well as for the prevention of inflammatory complications of transthoracic esophagectomy.
Health Pharmaceuticals Life Sciences European Union Hypertension Drug Development Inflammatory Diseases Rare Diseases Pulmonary Arterial Hypertension Esophageal Cancer Pulmonary Hypertension
Is PTEO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.194
52 Week Low 0.023
Average Volume 13,314
200-Day Moving Average 0.0
50-Day Moving Average 0.0594
20-Day Moving Average 0.0609
10-Day Moving Average 0.0369
Average True Range 0.0179
ADX 8.45
+DI 36.9956
-DI 38.7135
Chandelier Exit (Long, 3 ATRs ) 0.1403
Chandelier Exit (Short, 3 ATRs ) 0.0767
Upper Bollinger Band 0.1361
Lower Bollinger Band -0.0143
Percent B (%b) 0.29
BandWidth 246.962233
MACD Line -0.0107
MACD Signal Line -0.0067
MACD Histogram -0.004
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0300
Resistance 3 (R3) 0.0300 0.0300 0.0300
Resistance 2 (R2) 0.0300 0.0300 0.0300 0.0300
Resistance 1 (R1) 0.0300 0.0300 0.0300 0.0300 0.0300
Pivot Point 0.0300 0.0300 0.0300 0.0300 0.0300
Support 1 (S1) 0.0300 0.0300 0.0300 0.0300 0.0300
Support 2 (S2) 0.0300 0.0300 0.0300 0.0300
Support 3 (S3) 0.0300 0.0300 0.0300
Support 4 (S4) 0.0300